Jefferies Upgrades Immunomedics (IMMU) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Immunomedics (IMMU) Misses Q3 EPS by 2c
May 4, 2016 6:36 PM EDTImmunomedics (NASDAQ: IMMU) reported Q3 EPS of ($0.15), $0.02 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $900 thousand versus the consensus estimate of $2.13 million.
For earnings history and earnings-related data on Immunomedics (IMMU) click here.
... More